Literature DB >> 8678003

The effects of Helicobacter pylori colonization on gastric function and the incidence of portal hypertensive gastropathy in patients with cirrhosis of the liver.

K K Balan1, A T Jones, N B Roberts, J P Pearson, M Critchley, S A Jenkins.   

Abstract

OBJECTIVES: To investigate the prevalence of Helicobacter pylori infection in 50 cirrhotic patients with biopsy-proven cirrhosis with and without portal hypertensive gastropathy and to study whether or not the effects of H. pylori colonization of the stomach on gastric acid and pepsin secretion, serum gastrin and pepsinogen I levels, gastric mucus, and gastric emptying contributed to the development of portal hypertensive gastropathy in cirrhotics.
METHODS: All patients underwent an upper GI endoscopy followed by determination of basal and pentagastrin and insulin-stimulated gastric acid and pepsin secretion and serum gastrin and pepsinogen I levels. The gastric biopsies were stained to detect H. pylori infection, portal hypertensive gastropathy, and gastritis. The amount of gastric mucus was estimated by a microanalytical technique. The rate of gastric emptying was assessed by the radionuclide method using a semi-solid meal.
RESULTS: Thirty-three (66%) patients had endoscopic evidence of portal hypertensive gastropathy, 10 with the severe (20%) and 23 with mild form (46%). Twenty (40%) patients had histological evidence of H. pylori infection. Eleven out of 33 (33%) patients with endoscopic portal hypertensive gastropathy had microscopic evidence of H. pylori infection. Eighteen out of 20 (90%) patients with chronic active gastritis had concomitant H. pylori colonization. In contrast, the gastric mucosa was histologically normal in 21 of the 30 patients (70%) not infected with H. pylori. Marked hypochlorhydria and reduced pepsin secretion associated with a tendency to hypergastrinemia were observed in cirrhotic patients colonized with H. pylori compared with those without. However, there was no significant difference in serum pepsinogen I concentrations, the ratio of polymeric to degraded gastric mucus, or the rate of gastric emptying between cirrhotics with and without H. pylori colonization of the stomach. Furthermore, these parameters were not significantly different in patients with portal hypertensive gastropathy with and without H. pylori infection.
CONCLUSION: These observations suggest that H. pylori infection is unlikely to be involved in the pathogenesis of portal hypertensive gastropathy.

Entities:  

Mesh:

Year:  1996        PMID: 8678003

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  17 in total

Review 1.  Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.

Authors:  K W Burak; S S Lee; P L Beck
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

2.  Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.

Authors:  Mihajlo Gjeorgjievski; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2016-02-08

3.  A patient with impaired gastric motility.

Authors:  P A Paine; W Rees; C Babbs; J L Shaffer; G Armstrong; H Burnett; Q Aziz
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

4.  Gastric epithelial cell proliferation in patients with liver cirrhosis.

Authors:  A Zullo; A Romiti; V Rinaldi; A Vecchione; C Hassan; S Winn; S Tomao; A F Attili
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

5.  Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis.

Authors:  Tomotaka Akatsu; Masashi Yoshida; Shigeyuki Kawachi; Minoru Tanabe; Motohide Shimazu; Koichiro Kumai; Masaki Kitajima
Journal:  Dig Dis Sci       Date:  2006-10-06       Impact factor: 3.199

6.  Prevalence of Helicobacter pylori and occurrence of gastroduodenal lesions in patients with liver cirrhosis.

Authors:  Gabriele I Kirchner; Winfried Beil; Joerg S Bleck; Micheal P Manns; Siegfried Wagner
Journal:  Int J Clin Exp Med       Date:  2010-12-25

7.  No additive effect between Helicobacter pylori infection and portal hypertensive gastropathy on inducible nitric oxide synthase expression in gastric mucosa of cirrhotic patients.

Authors:  Usama A Arafa; Yasuhiro Fujiwara; Kazuhide Higuchi; Masatsugu Shiba; Toshiyuki Uchida; Toshio Watanabe; Kazunari Tominaga; Nobuhide Oshitani; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

8.  Helicobacter pylori infection is associated with greater impairment of cytochrome P-450 liver metabolic activity in anti-HCV positive cirrhotic patients.

Authors:  Edoardo Giannini; Alberto Fasoli; Federica Botta; Paola Romagnoli; Federica Malfatti; Bruno Chiarbonello; Mario Mamone; Vincenzo Savarino; Roberto Testa
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

9.  Gut proteases target Yersinia invasin in vivo.

Authors:  Janja Trček; Marc F Oellerich; Katy Niedung; Frank Ebel; Sandra Freund; Konrad Trülzsch
Journal:  BMC Res Notes       Date:  2011-04-18

10.  Peptic digestion of beef myofibrils is modified by prior marination.

Authors:  Nash Patel; Simon J M Welham
Journal:  Food Nutr Res       Date:  2013-05-23       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.